SYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic Complications

Clinical trial NCT04539678 · COMPLETED

Trial details

NCT number: NCT04539678
Sponsor: Nantes University Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Thrombotic Patients Diagnosis of Myeloproliferative Neoplasia Impact of Treatment With Cytoreducing Agent

Start date: 2019-05-21
Primary completion: 2023-12-31
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.